Skip to main content
SpringerLink
Log in

Ischemic Stroke and Transient Ischemic Attack: Long-Term Management and Secondary Prevention

  • Chapter
  • First Online:
Stroke Essentials for Primary Care

Part of the book series: Current Clinical Practice ((CCP))

  • 1123 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Prevalence of disabilities and associated health conditions among adults – United States, 1999. MMWR Morb Mortal Wkly Rep 2001;50:120–125.

    Google Scholar 

  2. Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics – 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007;115:e69–171.

    Article  PubMed  Google Scholar 

  3. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206–1252.

    Article  PubMed  CAS  Google Scholar 

  4. Sacco RL, Adams R, Albers G, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke 2006;37:577–617.

    Article  PubMed  Google Scholar 

  5. Seshadri S, Beiser A, Kelly-Hayes M, et al. The lifetime risk of stroke: estimates from the Framingham Study. Stroke 2006;37:345–350.

    Article  PubMed  Google Scholar 

  6. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033–1041.

    Google Scholar 

  7. Corvol JC, Bouzamondo A, Sirol M, Hulot JS, Sanchez P, Lechat P. Differential effects of lipid-lowering therapies on stroke prevention: a meta-analysis of randomized trials. Arch Intern Med 2003;163:669–676.

    Article  PubMed  CAS  Google Scholar 

  8. Amarenco P, Bogousslavsky J, Callahan A, 3rd, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006;355:549–559.

    Article  PubMed  CAS  Google Scholar 

  9. Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004;110:227–239.

    Article  PubMed  Google Scholar 

  10. Woo D, Gebel J, Miller R, et al. Incidence rates of first-ever ischemic stroke subtypes among blacks: a population-based study. Stroke 1999;30:2517–2522.

    Article  PubMed  CAS  Google Scholar 

  11. Ninomiya JK, L'Italien G, Criqui MH, Whyte JL, Gamst A, Chen RS. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation 2004;109:42–46.

    Article  PubMed  Google Scholar 

  12. Introduction. Diabetes Care 2004;27:1S–2.

    Google Scholar 

  13. Collins R, Armitage J, Parish S, Sleigh P, Peto R. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 2003;361:2005–2016.

    Article  PubMed  Google Scholar 

  14. Wolf PA, D'Agostino RB, Kannel WB, Bonita R, Belanger AJ. Cigarette smoking as a risk factor for stroke. The Framingham Study. Jama 1988;259:1025–1029.

    Article  PubMed  CAS  Google Scholar 

  15. Kurth T, Gaziano JM, Berger K, et al. Body mass index and the risk of stroke in men. Arch Intern Med 2002;162:2557–2562.

    Article  PubMed  Google Scholar 

  16. Suk SH, Sacco RL, Boden-Albala B, et al. Abdominal obesity and risk of ischemic stroke: the Northern Manhattan Stroke Study. Stroke 2003;34:1586–1592.

    Article  PubMed  Google Scholar 

  17. Ayala C, Greenlund KJ, Croft JB, et al. Racial/ethnic disparities in mortality by stroke subtype in the United States, 1995–1998. Am J Epidemiol 2001;154:1057–1063.

    Article  PubMed  CAS  Google Scholar 

  18. Disparities in deaths from stroke among persons aged <75 years – United States, 2002. MMWR Morb Mortal Wkly Rep 2005;54:477–481.

    Google Scholar 

  19. Ruland S, Hung E, Richardson D, Misra S, Gorelick PB. Impact of obesity and the metabolic syndrome on risk factors in African American stroke survivors: a report from the AAASPS. Arch Neurol 2005;62:386–390.

    Article  PubMed  Google Scholar 

  20. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991;22:983–988.

    Article  PubMed  CAS  Google Scholar 

  21. Lip GY, Edwards SJ. Stroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: a systematic review and meta-analysis. Thromb Res 2006;118:321–333.

    Article  PubMed  CAS  Google Scholar 

  22. Albers GW, Dalen JE, Laupacis A, Manning WJ, Petersen P, Singer DE. Antithrombotic therapy in atrial fibrillation. Chest 2001;119:194S–206S.

    Article  PubMed  CAS  Google Scholar 

  23. Chimowitz MI, Lynn MJ, Howlett-Smith H, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005;352:1305–1316.

    Article  PubMed  CAS  Google Scholar 

  24. Turan TN, Cotsonis G, Lynn MJ, Chaturvedi S, Chimowitz M. Relationship between blood pressure and stroke recurrence in patients with intracranial arterial stenosis. Circulation 2007;115:2969–2975.

    Article  PubMed  Google Scholar 

  25. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005;353:2034–2041.

    Article  PubMed  CAS  Google Scholar 

  26. Yokoe T, Minoguchi K, Matsuo H, et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003;107:1129–1134.

    Article  PubMed  CAS  Google Scholar 

  27. Bokinsky G, Miller M, Ault K, Husband P, Mitchell J. Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure. A preliminary investigation. Chest 1995;108:625–630.

    CAS  Google Scholar 

  28. Foster GE, Hanly PJ, Ostrowski M, Poulin MJ. Effects of continuous positive airway pressure on cerebral vascular response to hypoxia in patients with obstructive sleep apnea. Am J Respir Crit Care Med 2007;175:720–725.

    Article  PubMed  Google Scholar 

  29. Parish JM, Somers VK. Obstructive sleep apnea and cardiovascular disease. Mayo Clin Proc 2004;79:1036–1046.

    Google Scholar 

  30. Alajmi M, Mulgrew AT, Fox J, et al. Impact of continuous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnea: a meta-analysis of randomized controlled trials. Lung 2007;185:67–72.

    Article  PubMed  CAS  Google Scholar 

  31. Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc 1984;59:17–20.

    Google Scholar 

  32. Di Tullio M, Sacco RL, Gopal A, Mohr JP, Homma S. Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med 1992;117:461–465.

    PubMed  Google Scholar 

  33. Petty GW, Khandheria BK, Meissner I, et al. Population-based study of the relationship between patent foramen ovale and cerebrovascular ischemic events. Mayo Clin Proc 2006;81:602–608.

    Google Scholar 

  34. Nencini P, Baruffi MC, Abbate R, Massai G, Amaducci L, Inzitari D. Lupus anticoagulant and anticardiolipin antibodies in young adults with cerebral ischemia. Stroke 1992;23:189–193.

    Article  PubMed  CAS  Google Scholar 

  35. Vila P, Hernandez MC, Lopez-Fernandez MF, Batlle J. Prevalence, follow-up and clinical significance of the anticardiolipin antibodies in normal subjects. Thromb Haemost 1994;72:209–213.

    PubMed  CAS  Google Scholar 

  36. Cervera R, Font J, Gomez-Puerta JA, et al. Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome. Ann Rheum Dis 2005;64:1205–1209.

    Article  PubMed  CAS  Google Scholar 

  37. Levine SR, Brey RL, Tilley BC, et al. Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. Jama 2004;291:576–584.

    Article  PubMed  CAS  Google Scholar 

  38. Toole JF, Malinow MR, Chambless LE, et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. Jama 2004;291:565–575.

    Article  PubMed  CAS  Google Scholar 

  39. Gebreyohanns M, Adams RJ. Sickle cell disease: primary stroke prevention. CNS Spectr 2004;9:445–449.

    PubMed  Google Scholar 

  40. Kittner SJ, Stern BJ, Feeser BR, et al. Pregnancy and the risk of stroke. N Engl J Med 1996;335:768–774.

    Article  PubMed  CAS  Google Scholar 

  41. Fisher M, Davalos A. The MATCH study results in the context of secondary stroke prevention. Stroke 2004;35:2609.

    Article  PubMed  Google Scholar 

  42. Salem DN, Stein PD, Al-Ahmad A, et al. Antithrombotic therapy in valvular heart disease – native and prosthetic: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126:457S–482S.

    Article  PubMed  CAS  Google Scholar 

  43. Hart RG, Tonarelli SB, Pearce LA. Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas. Stroke 2005;36:1588–1593.

    Article  PubMed  Google Scholar 

  44. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449–1457.

    Article  Google Scholar 

  45. Wassertheil-Smoller S, Hendrix SL, Limacher M, et al. Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. Jama 2003;289:2673–2684.

    Article  PubMed  CAS  Google Scholar 

  46. Viscoli CM, Brass LM, Kernan WN, Sarrel PM, Suissa S, Horwitz RI. A clinical trial of estrogen-replacement therapy after ischemic stroke. N Engl J Med 2001;345:1243–1249.

    Article  PubMed  CAS  Google Scholar 

  47. Tzourio C, Tehindrazanarivelo A, Iglesias S, et al. Case-control study of migraine and risk of ischaemic stroke in young women. Bmj 1995;310:830–833.

    Article  PubMed  CAS  Google Scholar 

  48. Baillargeon JP, McClish DK, Essah PA, Nestler JE. Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis. J Clin Endocrinol Metab 2005;90:3863–3870.

    Article  PubMed  CAS  Google Scholar 

  49. Chan WS, Ray J, Wai EK, et al. Risk of stroke in women exposed to low-dose oral contraceptives: a critical evaluation of the evidence. Arch Intern Med 2004;164:741–747.

    Article  PubMed  Google Scholar 

  50. Bousser MG. Estrogens, migraine, and stroke. Stroke 2004;35:2652–2656.

    Article  PubMed  Google Scholar 

  51. Timsit SG, Sacco RL, Mohr JP, et al. Early clinical differentiation of cerebral infarction from severe atherosclerotic stenosis and cardioembolism. Stroke 1992;23:486–491.

    Article  PubMed  CAS  Google Scholar 

  52. Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Jama 1995;273:1421–1428.

    Article  Google Scholar 

  53. Cebul RD, Snow RJ, Pine R, Hertzer NR, Norris DG. Indications, outcomes, and provider volumes for carotid endarterectomy. Jama 1998;279:1282–1287.

    Article  PubMed  CAS  Google Scholar 

  54. Coward LJ, Featherstone RL, Brown MM. Safety and efficacy of endovascular treatment of carotid artery stenosis compared with carotid endarterectomy: a Cochrane systematic review of the randomized evidence. Stroke 2005;36:905–911.

    Article  PubMed  Google Scholar 

  55. Wendel-Vos GC, Schuit AJ, Feskens EJ, et al. Physical activity and stroke. A meta-analysis of observational data. Int J Epidemiol 2004;33:787–798.

    Article  PubMed  CAS  Google Scholar 

  56. Noda H, Iso H, Toyoshima H, et al. Walking and sports participation and mortality from coronary heart disease and stroke. J Am Coll Cardiol 2005;46:1761–1767.

    Article  PubMed  Google Scholar 

  57. Hu G, Sarti C, Jousilahti P, Silventoinen K, Barengo NC, Tuomilehto J. Leisure time, occupational, and commuting physical activity and the risk of stroke. Stroke 2005;36:1994–1999.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Resident in Neurology, University of Maryland School of Medicine, Baltimore, MD, USA

    Holly E. Hinson

Authors
  1. Holly E. Hinson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John W. Cole
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. The Neurology and Headache Treatment Center, Alexandria, VA, USA

    David Alway

  2. Baltimore VA Medical Center, University of Maryland, Baltimore, MD, USA

    John Walden Cole

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Hinson, H.E., Cole, J.W. (2009). Ischemic Stroke and Transient Ischemic Attack: Long-Term Management and Secondary Prevention. In: Alway, D., Cole, J.W. (eds) Stroke Essentials for Primary Care. Current Clinical Practice. Humana Press. https://doi.org/10.1007/978-1-59745-433-9_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-433-9_3

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-934115-01-5

  • Online ISBN: 978-1-59745-433-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation